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Introduction
The Na, K pump (Na, K-ATPase) functions to regulate the intracellular Na + concentration, [Na + ] i , by actively extruding 3 Na + in exchange for 2 K + [1] . Na, K-ATPase is therefore electrogenic, exerting an outward, hyperpolarising current, I p , which is known to influence the resting potential, V m and repolarisation [2] . The Na, K pump current has been measured directly in various cardiac tissues and myocytes isolated from sheep [3] , guinea pigs [4] , rabbits [5, 6] and dogs [7] . However, despite its potential to influence, or be influenced by, cardiac arrhythmias, I p has not yet been measured directly in cells or tissues from the human heart.
Chronic atrial fibrillation (AF) shortens the atrial action potential duration (APD) and effective refractory period (ERP), thus contributing to the stabilisation of the arrhythmia [8] [9] [10] [11] [12] [13] . The pattern of changes in ionic currents responsible for this is not fully understood. The density of atrial L-type Ca 2+ (I CaL ) and transient outward K + (I TO ) currents is consistently and markedly reduced in AF or rapid atrial pacing, in dogs [10] and humans [11] [12] [13] . However, recent work from our laboratory in human atrial cells [12] suggests that the shortening of APD and ERP by chronic AF cannot be explained by changes in these currents alone,
consistent with a mathematical model [14] , and data on the main alternatives are presently either unavailable, or in some cases, conflicting [13] .
The involvement or otherwise of I p or Na,K-ATPase in AF-induced atrial electrophysiological remodelling is presently unclear [13] . In sheep, short episodes of rapid atrial pacing increased the expression of atrial Na, K-ATPase [15] , although there was no effect on its activity [16] . In the goat model of AF, treatment with the I p blocker, digoxin, had either no effect on AF-induced changes in atrial ERP and AF inducibility [17] , or delayed their reversal [18] . However, I p was not measured directly in any of these studies, and has not yet, to our knowledge, been recorded in any model of rapid atrial pacing or AF.
It is conceivable that the shortening of atrial APD and ERP by chronic AF in humans might involve an increase in atrial I p . The aim was to test this hypothesis, by: 1) assessing the contribution of I p to human atrial cell APD and ERP; 2) measuring I p directly in atrial cells from patients in sinus rhythm (SR) and AF; 3) comparing the density, voltage-and extracellular [K + ] ([K + ] o )-sensitivity of I p between these patient groups.
Methods
The tip of the right atrial appendage was obtained from 25 consenting patients undergoing cardiac surgery. Procedures approved by the institutional research ethics committee were followed. The investigation conforms with the principles outlined in the Declaration of Helsinki [19] . Atrial cells were isolated by enzymatic dissociation and mechanical disaggregation, using protease (Type XXIV, Sigma) and collagenase (Type 1, Worthington), as described in detail previously [12] .
Action potentials and ion currents were recorded using the whole cell patch clamp technique.
Microelectrodes were pulled (Narishige PP-83) from filamented borosilicate glass tubes (Clark Electromedical) and heat polished to resistances of 3-7 MΩ. Cells were superfused at [35] [36] [37] o C, at 1.5-2 ml/min in a 200 µl perfusion chamber (RC-24E, Warner). An Axopatch-1D amplifier (Axon Instruments) and "WinWCP" software (donated by J Dempster, Strathclyde University) was used to stimulate and record electrical activity. Capacitative transients were compensated electronically prior to recording. Signals were low-pass filtered at 5 kHz and digitised (Digidata 1200 A-D converter, Axon) prior to storage on magnetic and compact discs.
Action potentials were recorded using an extracellular solution containing (mM): NaCl (130), KCl (4), CaCl 2 (2), MgCl 2 (1), glucose (10) and HEPES (10) , and a pipette solution containing: K-aspartate (110), KCl (20) , MgCl 2 (1), EGTA (0.15), Na 2 ATP (4), Na 2 GTP (0.4) and HEPES (5) . A liquid junction potential of +7±0.3 mV (n=6) was measured and compensated prior to seal formation. Action potentials were stimulated using 5 ms duration current pulses of 1.2x threshold strength, with an 8-pulse (S 1 ) conditioning train (75 beats/min). All cells were current-clamped (with hyperpolarising current of <150 pA) initially to a maximum diastolic potential (MDP) of ~-80 mV (measured from the 7th S 1 response) and the holding current was kept constant in each cell thereafter. The APD was calculated as the interval between the action potential upstroke and repolarisation to the level of 50, 75 and 90% (APD 50 , APD 75 and APD 90 , respectively).
Action potential restitution was measured by introducing a progressively premature test pulse (S 2 ) after the S 1 trains, with S 1 and S 2 of equal magnitude. From this, the cell's ERP was measured, as previously [12, 20] , as the longest S 1 -S 2 interval failing to elicit an S 2 response of amplitude >80% [21] of the preceding S 1 action potential. The action potential maximum upstroke velocity (V max ) was measured by automatically scanning phase 0 at high time resolution for the maximum slope between two adjacent voltage samples. Action potentials were recorded before and after superfusion with ouabain (10 µM) for 120 s, and again following 4 its removal. This concentration was chosen to avoid "rundown" of currents during the experimental protocols, since complete I p block by 1 µM ouabain required 6-10 min superfusion, whilst 10 µM ouabain required only 40-80 s (eg: see Fig 2) . 
Results

Patients' clinical characteristics
The patients' characteristics are shown in Table 1 . The majority of patients underwent coronary artery bypass graft surgery (76%) and suffered from angina (84%). Of patients in AF at the time of surgery, only those in which AF had persisted for longer than 3 months were included. Half of these patients underwent mitral valve surgery, versus none of those in SR. The medication taken by the patients is detailed in Table 1 and it is noteworthy that none of the patients in SR were taking digoxin, in contrast to 60% of patients in chronic AF. All patients on digoxin had been receiving the drug for longer than 2 months and patients received their routine cardiac drugs on the day of surgery.
Effects of superfusion with ouabain on human atrial cell action potentials and refractoriness
The I p blocker, ouabain (10 µM Table 2 . Ouabain depolarised the MDP by ~7 mV (Fig 1A and Table 2 
Human atrial I p was voltage-dependent
The steady-state voltage-dependency of I p was examined using rectangular voltage pulses, in cells from 9 patients in SR. Fig 3C) were similar to those of both the steady-state ( Fig 3A) and pseudo-steady-state (Fig 3B) currents, indicating that the voltagedependent characteristics of the K + o -evoked current were those of I p . (Fig 5A, open circles) . The mean I p at 5.4 and 10 mM K 
Long-term digoxin therapy in patients with AF was associated with a small reduction in I p
Sixty percent of the patients who were in chronic AF were treated pre-operatively with digoxin, versus none of the patients in SR ( 
Atrial I p was similar in the non-digoxin-treated patients in AF to that of the patients in SR
The concentration-response relationship for the effect of K (Fig 6Bi) and similar mean EC 50 and E max values (Fig 6Bii) between the two patient groups.
Discussion
The Na, K pump current, I p , was measured directly for the first time to our knowledge in human myocardium, and was shown to have similar characteristics to those recorded in several other species, including the responses to extracellular potassium, voltage and ouabain [3] [4] [5] [6] [7] . The half-maximal response to K + o was within the reported range (1.0-2.8 mM), and the I p -voltage relationship was linear, in line with the majority of studies, although this may have been influenced by incomplete K + current suppression, since I p saturation was reported at 0 mV [6] . In addition, evidence has been provided, novel in any species, of a lack of change in atrial I p associated with chronic AF, and also of a reduction in I p associated with long-term digoxin therapy.
In cells from patients in chronic AF, I p displayed a similar density, voltage-and [K + ] o -sensitivity to that of cells from patients in SR, indicating that a change in neither the density nor functional properties of atrial I p is involved in human AF-induced atrial electrophysiological remodelling. This is in line with the reported absence of change in atrial Na, K-ATPase activity following 2 hours of AF in sheep [16] , and with the lack of effect of digoxin on atrial electrophysiological remodelling produced by 24 hours of AF in goats [17] , although in the latter model, digoxin delayed the reversal of such remodelling [18] . However, the magnitude [3, 4, 6, 7] , as confirmed by the present data, which would contribute to the shortening of atrial APD and ERP during AF. However, I p cannot be the major factor since atrial electrophysiological remodelling is observed in human atrial isolated cells even when the ionic concentrations are controlled [10] [11] [12] [13] 25] .
Long-term digoxin therapy was associated with a small reduction in atrial I p . This was consistent with the reported reduction by digoxin therapy in the hyperpolarisation caused by rewarming of human atrial tissue considered due to reactivation of the Na,K pump following [Na + ] i -loading [23] . The present magnitude of I p reduction, of ~20%, corresponded with the reported percentage occupancy of digitalis receptors in chronically digitalised failing human ventricle, measured after protracted washing of tissues in anti-digoxin antibodies [26] . Alternatively, the observed reduction in I p may represent an adaptive change analogous to the pharmacological remodelling of human atrial ion currents by chronic β-blockade [20] . Such a process would be consistent with the reduction in the number of Na, K-ATPase sites in HeLa cells exposed to ouabain [27] . It is not known whether the I p reduction was influenced mainly by residual receptor occupancy 10 or by pharmacological remodelling. Since digoxin increased the sensitivity of I p to K + o , an effect on the Na,K-ATPase α-2 isoform is a possibility, since its activity is strongly dependent on [K + ] o [28] . Long-term ACE inhibition did not affect human atrial I p , in agreement with the reported lack of effect on human atrial cell action potentials and ERP [20] . There have been no previous reports of effects of ACE inhibitors on human atrial I p , although ventricular I p was increased in captopril-treated rabbits, due to a reduction in interstitial and/or intracellular concentrations of angiotensin II, and not to a change in Na, K-ATPase expression [24] .
A change in atrial I p , whether by digoxin therapy as observed here, or by altered voltage and/or ionic conditions during AF in the absence of an electrophysiologically-remodelled Na,K pump would affect the APD and ERP, particularly with the high input resistance of human atrial cells [12, 20] . Our results with ouabain suggested the potential for such an effect. It should be noted, however, that although ouabain completely blocked I p and prolonged the APD and ERP in cells in-vitro, the degree of block in-vivo in patients treated with digoxin would be less (and possibly as low as the observed 19% reduction in E max ), and the consequent effect on the APD and ERP may also, therefore, be predicted to be less than that observed invitro. No reports of effects of cardiac glycosides on action potentials in human atrial cells were found, but a small prolongation in atrial ERP was reported in patients administered ouabain [29] or digoxin [30] .
However, acute digoxin had no effect on the ERP in goats [17, 18] and APD-shortening by digitalis has also been reported [31, 32] . In human atrial fibres [31] , APD-shortening was secondary to vagal stimulation, but in guinea pig ventricular myocytes [32] , it was due to a secondary ionic effect of I p block, namely attenuation of the normally inward Na + /Ca 2+ exchanger current (I Na/Ca ) by ouabain-induced [Na + ] i -loading. The effects of digitalis on the APD and ERP in-vivo therefore result from a complex interaction between direct and secondary effects of I p blockade and effects of vagal stimulation. It is also the case that the measurement of ERP that is made in single cells is not identical to that made in-vivo, since ERP is conventionally measured in terms of propagation failure, which cannot be measured in single cells. Nevertheless, action potentials of amplitude >80% of normal, as used here to define the cell ERP, have been shown to propagate, with graded responses occurring at lower amplitudes [21] . Additionally, 10 µM ouabain may affect action potentials via currents additional to I p , such as I CaL [33] . However, since I CaL blockade with nifedipine had no effect on V m or ERP in human atrial cells [12] , this suggests that 10 µM ouabain largely affected these measurements by blocking I p , supported by a mathematical model [5] .
Digoxin is used clinically as an inotropic drug to improve haemodynamic function, and also for ventricular rate control during AF, through central and peripheral augmentation of vagal tone to prolong the [13] . Either or both of these influences on the APD may explain the reported delay by digoxin of recovery from AF-induced atrial electrophysiological remodelling in goats [18] , and may also contribute to the lack of efficacy of digoxin in converting human AF [35] . Of note, in previous studies of human atrial cellular electrophysiological remodelling, the majority of patients in AF were taking digoxin [11, 12, 25] . However, any influence on the APD of [Na + ] i -loading would have been removed by the controlled [Na + ] i in each of these studies. Moreover, in the presence of residually-bound or down-regulated digoxin receptors, a reduction in the hyperpolarising and repolarising influences of I p would contribute a direct APD-lengthening effect, as observed here with ouabain. Thus, the reported APDshortening associated with chronic AF in human atrial cells [11, 12] may have been underestimated.
In conclusion, the present data indicate that chronic AF in humans, in the absence of the influence of digoxin therapy, was not associated with a significant change in the density of atrial I p , or in its sensitivity to voltage or extracellular K + . 
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